Introduction
Leading pharmaceutical firm has announced a major strategic investment by acquiring an operational API manufacturing facility in Telangana worth rs 25.5 crore, aimed at boosting capacity, expanding product portfolio.
Also Read: Tac Infosec: Stock hits 5% upper circuit after announcing 1:1 bonus shares
Share price movement of Sudarshan Pharma
On September 8, 2025, Sudarshan Pharma Industries Ltd opened at ₹32.13, up 2.00% from its previous close of ₹31.50. The stock touched a high of ₹32.13 and a low of ₹31.00. By 4:00 PM, it traded at ₹32.13, with a market cap of ₹773.24 crore.
Sudarshan Pharma Expands Capacity with Srigen Deal
Sudarshan Pharma Industries Limited announced a strategic capex investment after signing a definitive agreement with Srigen Lifesciences Private Limited. The deal involves acquiring land, building, and plant machinery at an operational API manufacturing facility in Telangana worth rs 25.5 crore.
The acquisition will expand Sudarshan Pharma’s manufacturing capacity. The facility will be used for producing high-value pharmaceutical ingredients like Ropivacaine, Bupivacaine, Probenecid, Sitagliptin, Apixaban, and Rivaroxaban. These APIs have strong demand across regulated and semi-regulated markets.
This investment is part of the company’s strategy to build a scalable and compliance-driven infrastructure. The facility will help vertical integration, improve operational efficiency, and support long-term growth in the API and specialty chemicals sector.
Stock performance of Sudarshan Pharma for Period of 1 week, 6 months, and 1 year
Sudarshan Pharma Industries Ltd delivered a 0.03% return over the past week, gained 10.8% in the past six months, and rose 35.5% over the past year.
Also Read: NTPC Green Energy: Stock jumps after signing MoU with VOC port authority
Shareholding pattern of Sudarshan Pharma
| Particulars | Jun 2025 | Mar 2025 | Sep 2024 |
| Promoter | 57.40% | 57.40% | 57.40% |
| FII | 19.50% | 18.50% | 13.10% |
| DII | 0.10% | 0.00% | 0.00% |
| Public | 23.10% | 24.20% | 29.50% |
About Sudarshan Pharma
Sudarshan Pharma Industries Limited (BSE: 543828) is a Mumbai-based pharmaceutical and specialty chemical company. It manufactures and markets APIs, intermediates, specialty chemicals, and formulations, serving domestic and global markets with advanced R&D and compliant facilities.
Stay Ahead with the Latest Stock Market Updates – Click Here
Disclaimer: The above article is written for educational purposes, and the companies’ data mentioned in the article may change with respect to time. The securities quoted are exemplary and are not recommendatory.
FAQs
Q: Why is Sudarshan Pharma Industries Limited share price going up today?
A: Sudarshan Pharma Industries Limited share price rose after announcing a strategic investment in Srigen Lifesciences’ Telangana API facility.
Q: What does Sudarshan Pharma Industries Limited specialize in?
A: Sudarshan Pharma Industries Limited specializes in manufacturing APIs, intermediates, specialty chemicals, and formulations for domestic and global markets.
Q: What is the market capitalization of Sudarshan Pharma Industries Limited?
A: The market capitalization of Sudarshan Pharma Industries Limited is ₹773.24 crore as of September 8, 2025.


